In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …

The outbreak of coronavirus disease 2019 (COVID-19) in December 2019 in Wuhan, China,
introduced the third highly pathogenic coronavirus into humans in the 21st century. Scientific …

Acute respiratory distress syndrome (ARDS) and robust cytokine storm are the hallmark of
severe COVID-19 cases. Using single-cell RNA sequencing of bronchoalveolar lavage fluid …

Objectives The severity of Coronavirus Disease 2019 (COVID-19) is largely determined by
the immune response. First studies indicate altered lymphocyte counts and function …

SARS-CoV-2 has been identified as the causative agent of a global outbreak of respiratory
tract disease (COVID-19). In some patients, the infection results in moderate to severe acute …

The present outbreak of lower respiratory tract infections, including respiratory distress
syndrome, is the third spillover, in only two decades, of an animal coronavirus to humans …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated
with a hyperinflammatory state and lymphocytopenia, a hallmark that appears as both …

Background The coronavirus disease 2019 (COVID-19) pandemic continues to produce
substantial morbidity and mortality. To understand the reasons for the wide-spectrum …

Human lung epithelial cells are likely among the first targets to encounter invading severe
acute respiratory syndrome-associated coronavirus (SARS-CoV). Not only can these cells …

Vaccines are essential to control the spread of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) and to protect the vulnerable population. However, one safety …